Telix Pharmaceuticals Ltd. (AU:TLX) has released an update.
Telix Pharmaceuticals Limited has announced the cessation of various securities, including share rights, share appreciation rights, and options, due to the non-fulfillment of underlying conditions. The affected securities had various lapse dates in 2024, with a total number of 681,762 securities ceasing. Investors are alerted to these changes, which may influence the company’s stock performance.
For further insights into AU:TLX stock, check out TipRanks’ Stock Analysis page.
